Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Translocation of Proteins into the Mitochondria

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<i>De Novo</i> Design of Peptide Masks Enables Rapid Generation of Conditionally-Active Miniprotein Binders.

Journal of the American Chemical Society·2025

Same author

Development of simplified poly(β-aminoester)-zwitterion nanovehicles for controlled cancer cell transfection and enhanced gene delivery across a cell-based model of the blood-brain barrier.

Drug delivery and translational research·2025

Same author

A Site-Specific MiniAp4-Trastuzumab Conjugate Prevents Brain Metastasis.

Molecular pharmaceutics·2025

Same author

BrainBike peptidomimetic enables efficient transport of proteins across brain endothelium.

RSC chemical biology·2024

Same author

Chemically Enhanced Peptide and Protein Therapeutics.

Pharmaceutics·2023

Same author

Protease-Resistant Peptides for Targeting and Intracellular Delivery of Therapeutics.

Pharmaceutics·2021

Same journal

Mechanistic Insight into Self-Gelation Involved in Prescription Design for Optimization of Tablet Performance.

Molecular pharmaceutics·2026

Same journal

[<sup>68</sup>Ga]Ga-DOTA-DP-UBI 29-41: A Novel <sup>68</sup>Ga-Labeled Ubiquicidin 29-41 Derivative Containing d-Proline for Bacterial Infection PET Imaging.

Molecular pharmaceutics·2026

Same journal

Comparative Investigation of the Impact of Sodium Citrate Buffers on Lipid Nanoparticles of circRNA or Linear mRNA.

Molecular pharmaceutics·2026

Same journal

Preclinical Evaluation of <sup>177</sup>Lu-Labeled Anti-CLDN18.2 VHH-Fc for Radioimmunotherapy in Gastric Cancer.

Molecular pharmaceutics·2026

Same journal

The Impact of Plasticizer Polarity on the Permeability of Hydroxypropyl Methylcellulose Phthalate Films.

Molecular pharmaceutics·2026

Same journal

Call For Papers: Molecular Understanding and Formulation Design for Peptide Delivery.

Molecular pharmaceutics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 29, 2025

Preparation of Synaptoneurosomes from Mouse Cortex using a Discontinuous Percoll-Sucrose Density Gradient

Preparation of Synaptoneurosomes from Mouse Cortex using a Discontinuous Percoll-Sucrose Density Gradient

Published on: September 17, 2011

New Trends in Brain Shuttle Peptides.

Roger Prades¹, Meritxell Teixidó², Benjamí Oller-Salvia³

¹Accure Therapeutics, Barcelona Science Park 08028 Barcelona, Spain.

Molecular Pharmaceutics

|February 3, 2025

Summary

This summary is machine-generated.

Developing brain shuttle peptides offers a promising strategy to overcome the blood-brain barrier (BBB) for treating central nervous system diseases. This review highlights advancements in peptide shuttle development and their potential for clinical translation.

Keywords:

Blood−brain barrier brain shuttle central nervous system therapeutics drug delivery peptide shuttle

More Related Videos

Quantifying the Heterogeneous Distribution of a Synaptic Protein in the Mouse Brain Using Immunofluorescence

Quantifying the Heterogeneous Distribution of a Synaptic Protein in the Mouse Brain Using Immunofluorescence

Published on: January 29, 2019

Brain Slice Biotinylation: An Ex Vivo Approach to Measure Region-specific Plasma Membrane Protein Trafficking in Adult Neurons

Brain Slice Biotinylation: An Ex Vivo Approach to Measure Region-specific Plasma Membrane Protein Trafficking in Adult Neurons

Published on: April 3, 2014

Related Experiment Videos

Last Updated: May 29, 2025

Preparation of Synaptoneurosomes from Mouse Cortex using a Discontinuous Percoll-Sucrose Density Gradient

Preparation of Synaptoneurosomes from Mouse Cortex using a Discontinuous Percoll-Sucrose Density Gradient

Published on: September 17, 2011

Quantifying the Heterogeneous Distribution of a Synaptic Protein in the Mouse Brain Using Immunofluorescence

Quantifying the Heterogeneous Distribution of a Synaptic Protein in the Mouse Brain Using Immunofluorescence

Published on: January 29, 2019

Brain Slice Biotinylation: An Ex Vivo Approach to Measure Region-specific Plasma Membrane Protein Trafficking in Adult Neurons

Brain Slice Biotinylation: An Ex Vivo Approach to Measure Region-specific Plasma Membrane Protein Trafficking in Adult Neurons

Published on: April 3, 2014

Area of Science:

Neuroscience
Pharmacology
Biotechnology

Background:

The blood-brain barrier (BBB) presents a significant obstacle for delivering drugs to the central nervous system (CNS).
The BBB's selective transport mechanisms offer potential routes for therapeutic delivery.
Brain shuttle systems aim to leverage these mechanisms for targeted drug delivery.

Purpose of the Study:

To review the progress in brain shuttle peptide development from 2015 to 2025.
To identify key trends and strategies in enhancing peptide shuttle efficiency.
To compare peptide shuttles with other brain delivery systems and assess their clinical translation potential.

Main Methods:

Literature review of scientific publications from 2015-2025.
Analysis of utilized brain shuttle peptides and development strategies.
Comparative assessment of different brain shuttle modalities.

Main Results:

Significant advancements in peptide shuttle design and optimization have been observed.
Certain peptides have emerged as highly utilized and effective brain shuttles.
Strategies to enhance transport efficiency include peptide modification and conjugation.
Peptide shuttles show comparable or superior performance to other delivery systems in some contexts.

Conclusions:

Peptide shuttles represent a rapidly advancing field with considerable potential for CNS drug delivery.
Continued research and development are crucial for optimizing peptide shuttles for clinical applications.
The clinical translation of peptide shuttles is progressing, offering new hope for treating neurological disorders.